BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Lone Star Bio

  US Oncology, Inc. Release: New Study Demonstrates Nonanthracycline Adjuvant Regimen TC (Docetaxel And Cyclophosphamide) Is Superior To Standard AC (Doxorubicin/Cyclophosphamide) For Early Breast Cancer

  December 12, 2005

   · 

  4 min read
• Pharm Country

  Quest Diagnostics Inc. Announces The Availability Of A New Gene-Based Assay To Help Physicians Identify The Primary Site Of A Metastatic Cancer Of Unknown Origin

  December 12, 2005

   · 

  3 min read
• BioMidwest

  Baxter Healthcare Corporation Launches First Sevoflurane In China And Announces Phased Launch In Other Countries In 2006

  December 12, 2005

   · 

  3 min read
• American Society of Hematology Release: Studies Highlight Need For Safe, Effective Therapies To Treat And Prevent Thromboembolic Events Following Orthopedic Surgery

  December 12, 2005

   · 

  6 min read
• Biotech Bay

  Bionovo, Inc. To Present At 9th Annual New York Society Of Security Analysts Biotech/Specialty Pharma Conference

  December 12, 2005

   · 

  2 min read
• Business

  Innocoll, Inc. Announces New Distribution Agreements For CollaRx GENTAMICIN SURGICAL IMPLANT

  December 12, 2005

   · 

  2 min read
• Drug Development

  Amgen Release: Interim Long-Term Follow-Up Data Show AMG 531 Increases Platelets In Patients With Immune Thrombocytopenic Purpura; Results Suggest Once-Weekly Dosing Of AMG 531 Results In Sustained Platelet Response

  December 12, 2005

   · 

  1 min read
• Drug Development

  TRANSGENE Releases Positive Phase I/II Data Of TG1042 (Ad-IFNg) And Plans For A Pivotal Study In Cutaneous B-Cell Lymphoma

  December 12, 2005

   · 

  5 min read
• Drug Development

  Allos Therapeutics, Inc. Release: Retrospective Analysis Finds EFAPROXYN(TM) Extends Survival With Quality Of Life In Patients With Brain Metastases Originating From Breast Cancer

  December 12, 2005

   · 

  6 min read
• Drug Development

  Seattle Genetics, Inc. Reports SGN-40 Clinical Data At The American Society Of Hematology Annual Meeting

  December 12, 2005

   · 

  1 min read